Highly Purified Menotropin (HP-hMG) Versus Recombinant FSH (rFSH) Plus Recombinant LH (rLH) in Intrauterine Insemination Cycles in Women ≥35 Years: a Prospective Randomized Trial.

• Status: Completed
• Trial end date: 2013-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study evaluates the effects of different therapies in ovulation induction in Intrauterine Insemination Cycles.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Catholic University of the Sacred Heart

Criteria

Inclusion Criteria:

• women with story of infertility sine causa and mild-moderate male factor

• regular ovulatory menstrual cycles

• BMI ≤27 kg/m2

• normal day 3 hormonal pattern

• bilateral tubal patency

Exclusion Criteria:

• mono/bilateral tubal occlusion,

• severe male factor

• polycystic ovarian syndrome or any systemic disease or endocrine or metabolic abnormalities

• pelvic inflammatory disease

• endometriosis

• sexual organ malformations

• neoplasms or breast pathology incompatible with gonadotropin stimulation.